Dianthus Therapeutics | MGTA - Trade Creditors


Dianthus Therapeutics reported $6.7M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Akebia Therapeutics USD 10.09M 1.47M Sep/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Avita Medical AUD 7.27M 976K Jun/2025
Celltrion KRW 104.19B 15.67B Sep/2025
Cspc Pharmaceutical CNY 2.09B 42.45M Jun/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 6.7M 1.3M Sep/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 6.49M 1.35M Jun/2025
Moderna USD 317M 50M Dec/2025
Neuren Pharmaceuticals AUD 6.66M 5.21M Jun/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Organon & Co USD 1.07B 7M Sep/2025
Ovoca Bio EUR 209K 242K Dec/2024
Pharma Mar EUR 43.8M 6.72M Sep/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Revvity USD 185.46M 9.66M Dec/2025
Sartorius EUR 323.2M 61M Sep/2025
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tectonic Therapeutic USD 1.48M 1.32M Sep/2025
Tilray USD 107.35M 8.43M Mar/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025
Zz Pientze Pharmaceu CNY 516.14M 31.53M Sep/2025